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Abstract
Determination of the precise composition and variation of microbiota in cystic fibrosis lungs is crucial since chronic
inflammation due to microorganisms leads to lung damage and ultimately, death. However, this constitutes a major
technical challenge. Culturing of microorganisms does not provide a complete representation of a microbiota, even when
using culturomics (high-throughput culture). So far, only PCR-based metagenomics have been investigated. However, these
methods are biased towards certain microbial groups, and suffer from uncertain quantification of the different microbial
domains. We have explored whole genome sequencing (WGS) using the Illumina high-throughput technology applied
directly to DNA extracted from sputa obtained from two cystic fibrosis patients. To detect all microorganism groups, we
used four procedures for DNA extraction, each with a different lysis protocol. We avoided biases due to whole DNA
amplification thanks to the high efficiency of current Illumina technology. Phylogenomic classification of the reads by three
different methods produced similar results. Our results suggest that WGS provides, in a single analysis, a better qualitative
and quantitative assessment of microbiota compositions than cultures and PCRs. WGS identified a high quantity of
Haemophilus spp. (patient 1) or Staphylococcus spp. plus Streptococcus spp. (patient 2) together with low amounts of
anaerobic (Veillonella, Prevotella, Fusobacterium) and aerobic bacteria (Gemella, Moraxella, Granulicatella). WGS suggested
that fungal members represented very low proportions of the microbiota, which were detected by cultures and PCRs
because of their selectivity. The future increase of reads’ sizes and decrease in cost should ensure the usefulness of WGS for
the characterisation of microbiota.
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Introduction
The physiological importance of microbiota present in different
localisations of the human body is increasingly recognised and the
human microbiota is now considered to be a ‘‘human organ’’ [1].
The composition of microbiota and their variation over time are
considered to be involved in the development of infectious diseases
(post-antibiotic colitis) and non-infectious diseases (obesity, asth-
ma). The lung microbiota of cystic fibrosis (CF) patients also plays
a crucial role in the pathophysiology of the CF disease and this is
of major importance since impairment of the lungs is the leading
cause of death for these patients. Due to the pathophysiological
defect of the CF transmembrane conductance regulator at the
apical surface of the airways, CF lung disease is characterised by a
vicious cycle of chronic airways inflammation and infection that
leads to the injury of the lung parenchyma with progression to
premature death. Healthy lungs were considered to be sterile until
recently. There is now increasing evidence that the bronchi
harbour a specific microbiome in healthy individuals as well as in
CF patients [2,3]. The currently used antibiotic treatments have
incontestably increased the life expectancy of CF patients.
Nevertheless, these combinations of antibiotics may also cause
‘‘collateral’’ damage due to the development of resistance, with the
consequence of no further significant increase of life expectancy.
More therapeutic options for CF lung disease could become
available in the future, by targeting other pathogens than
Staphylococcus aureus, Pseudomonas aeruginosa, and Aspergillus fumigatus,
by discovering new therapeutic strategies, like for example
adapting lung environments [4], or by identifying beneficial
probiotic microorganisms. For that purpose, it is important to have
a holistic view of the lung microbiota of CF patients, including not
only bacteria but also fungi and viruses. This holistic view is also
needed because there is evidence of signalling interactions between
species of a given biological domain (bacteria or eukarya), but also
between species of different domains, either as pathogens,
commensals or synergetic microorganisms [5].
Determining the composition of CF lung microbiota is not
straightforward and constitutes a major technical challenge [6,7].
Indeed, the media used in classical microbial culture methods only
allow identification of cultivable microorganisms and of selected
groups of microorganisms. Even using culturomics, there is still a
huge gap between recovered microbes and those detected by
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metagenomics [8,9]. Obviously, cultivable microorganisms only
correspond to a small fraction of the total microbiota. Therefore,
recent studies investigate the usefulness of molecular biology to
obtain a more comprehensive composition of microbiota [10].
PCR amplification of the genes encoding the ribosomal RNAs
followed by high-throughput DNA sequencing (HTS) has been
largely used so far because large databases of these sequences exist.
These studies almost exclusively targeted bacteria using 16S rRNA
[2,11,12,13,14,15] and only few studies analysed fungi using the
internal transcribed spacers (ITS) [16,17]. The data presently
available suggest a bacterial diversity of the CF lung microbiota
that increases in childhood [11], followed by a progressive decline
during adulthood [12]. A greater diversity appeared to be
associated with better lung functions. The most common
organisms observed in CF lungs are S. aureus, Haemophilus influenzae,
P. aeruginosa, Burkholderia cepacia, and A. fumigatus. The clinical
importance of A. fumigatus and other fungi in CF remains
controversial. Nevertheless, fungi and bacteria are known to
interact at the cellular level [18], specifically P. aeruginosa with A.
fumigatus [19], or P. aeruginosa with Candida albicans [18].
However, the PCR approach used so far suffers from several
limitations and may introduce biases in the observed microbiota
compositions. Indeed, selected groups of organisms will be
preferentially amplified by the primers, as demonstrated for the
fungal ITSs [20]. Even broad-range eubacterial 16S rRNA PCR
generally do not amplify all eubacteria, since Spirochetes and
Chlamydia for instance exhibit highly divergent sequences. PCR
also implies the risk of missing as yet unknown microorganisms
which are not amplifiable because of alternate target sequences.
Consequently, running several PCRs in parallel is necessary to
obtain a comprehensive composition of the microbiota, but this
prevents a relative quantification of the different microorganism
groups between each other. There is thus a need to improve the
determination of the composition of microbiota in order to get
quantitative and complete results. The aim of the present work
was to assess the usefulness of whole genome sequencing (WGS)
using the Illumina HTS technology applied directly to DNA
extracted from CF respiratory clinical samples.
Materials and Methods
Ethics Statement
We obtained informed consent from the two 14 and 17 year old
female patients as well as from their next of kin. The obtained
consent was verbal in agreement with the institutional review
board, the Ethics Committee of the Canton of Vaud, Lausanne,
Switzerland. Written consent was not necessary because the
analysis was performed using left-overs of clinical samples. The
oral consent was recorded in the patients’ medical documentation.
The institutional review board approved the study protocol (No.
352/11).
Specimens
Two spontaneous sputa were collected in 2012 from adolescent
female CF patients at the paediatric outpatient clinic of the Centre
Hospitalier Universitaire Vaudois. They were processed on the
day of collection for cultures in the microbiology diagnostic
laboratory, and then stored at 220uC before DNA extraction.
Cultures
The routine procedure for culturing respiratory specimens from
CF patients was applied in the microbiology laboratory. Briefly,
five different agar media were used in Petri dishes. All media are
from Becton Dickinson (Allschwil, Switzerland), except the
MacConkey medium which is from Biolife (Milano, Italia). The
MacConkey medium was incubated for 48 hours in an aerobic
atmosphere, whereas the Columbia and Chocolate-bacitracin agar
were incubated in a 5% CO2 atmosphere. Specific cultures were
carried out to detect B. cepacia at 37uC for 72 hours in an aerobic
atmosphere on the Oxidation/Fermentation-Polymyxin-Bacitra-
cin-Lactose (OFPBL) agar. Bacterial growth was scored semi-
quantitatively for each species, and each strain was identified using
conventional procedures. Species considered as possible pathogens
(e.g. H. influenzae, S. aureus, Achromobacter sp. and P. aeruginosa) were
identified using matrix-assisted laser desorption ionisation time-of-
flight (MALDI-TOF) mass spectrometry using a cut-off of 2 for
identification at species level, and of 1.7 at genus level [21].
MALDI-TOF proved to be a very good tool for identifying non-
fermentable bacteria. Filamentous fungi and yeasts were cultured
at 30uC for up to seven days in an aerobic atmosphere on the
Sabouraud medium supplemented with 0.5 g/l chloramphenicol
and 0.04 g/l gentamicin to prevent bacteria growth. Growth of
yeasts and Candida spp. were scored semi-quantitatively, using the
four-quadrant method. Filamentous fungi growth was scored by
reporting the total number of fungal colonies, and the colonies
were identified morphologically upon sporulation on potato
dextrose medium (Becton Dickinson).
DNA Extraction using Four Methods in Parallel
To avoid contamination, DNA extraction was performed under
a laminar flow situated in a different room from where subsequent
PCR amplification and sequencing steps were carried out. Each
sputum was liquefied by the addition of one volume of fresh 2%
w/v N-acetyl-L-cystein in Tris-Na-citrate-di-hydride 1.5% w/v
pH 8.5, and by vortexing and agitating for at least 30 minutes on a
rotating agitator. After centrifugation at 3000 g for 15 minutes, the
pellet was resuspended in a volume of supernatant equal to the
initial volume of the sputum. To improve the recovery of genomic
DNA and thus to permit an exhaustive evaluation of the microbial
diversity, four methods of lysis were used. Practically, the liquefied
sputum was separated in four aliquots of 200 microlitres: one was
used for direct DNA extraction (see below), and three for the
following different lysis procedures performed before DNA
extraction. One aliquot was incubated for 15 minutes at 95uC
followed by incubation in a sonication bath for 10 minutes
(procedure for mycobacteria of our molecular diagnostic labora-
tory). The two other aliquots were subjected to beads-beating for
30 or 45 seconds: after the addition of an equal volume of Bacteria
Lysis Buffer and brief vortexing, each aliquot was transferred to a
dedicated tube containing MagNA Lyser green beads, and shaken
at 6,000 rpm in the MagNA Lyser agitator (reagents and device:
Roche, Basel, Switzerland; procedure for fungi of our molecular
diagnostic laboratory). The tubes were then centrifuged for 10
minutes at 10,000 rpm, and 100 microlitres of the supernatant
were transferred into a new tube. DNA was then extracted using a
QIAamp DNA mini-kit (including lysis with proteinase K, Qiagen:
Hilden, Germany) according to the manufacturer’s instructions.
The four DNA extracts were mixed in equal amounts. The
resulting DNA mixture from sputa 1 and 2 were 66 and 312 ng/
ml respectively.
WGS by Illumina HTS
Single-end libraries were prepared using Illumina TruSeqDNA
Sample Prep reagents and 1.3 or 1.4 micrograms of the DNA
mixture obtained from sputa 1 or 2 respectively. Multiplex
sequencing produced 95,507,767 and 101,556,686 reads respec-
tively with an average length of 100 nucleotides.
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Illumina HTS Read Filtering
Prior to any analysis, most of the human reads were filtered out
of the two datasets by aligning all the reads onto the UCSC hg19
human genome using Bowtie [22] with a seed of 75 and allowing
one mismatch. This reduced the number of reads to 16,233,617
(17.0%) and 20,191,018 (19.8%) for sputa 1 and 2 respectively.
The metagenomics data were not deposited in a publicly available
database because they contain information (human genome reads)
that could allow identification of the patients, even after filtration.
Nevertheless, the data are available for research purposes upon
request.
Search for Bacterial Sequences among Filtered HTS Reads
Phylogeny analyses of the unassembled Illumina reads were
then performed using BLAST against SILVA rRNA library [23],
as well as using MetaPhlan [24] and MetaPhyler [25], according
to the instructions. We considered only reads that could be
attributed to a bacterial taxon and representing at least 0.1% of
the whole population of microbial genera/species observed in a
given microbiota.
Search for Fungal Sequences among Filtered HTS Reads
We searched for fungal ITSs of the rRNA operon in the non-
filtered datasets using BLAST against the ITSoneDB [26] and
UNITE [27] databases for ITS1, and against the ITS2 database
IV [28] and UNITE databases for ITS2. We also searched for
homology between the reads and all currently available fungal
proteins in UniProt using blastx [29]. As these protein searches
were computationally demanding on the complete datasets, we
only performed them on 1% of the filtered datasets. As an
additional control, we used Bowtie (seed of 75, 1 mismatch) to map
the reads of the two non-filtered datasets on different genomes of
the genus Candida (www.candidagenome.org), and of the genus
Aspergillus (http://www.aspergillusgenome.org).
Eubacterial PCR Targeting 16S rRNA
The eubacterial PCR described by Delhaes et al [16] was used.
It amplifies a ca. 465 bps region containing the complete V3
domain of most prokaryotic 16S ribosomal DNA genes. This PCR
is known to amplify more than 95% of the species of all eubacterial
phyla, except for the following phyla of which only 5 to 90% of the
species are amplified: Chlamydiae, Chlorobacteria, Cyanobacte-
ria, Planctomycetes and Verrucomicrobia [30]. The primers were
3271-16S-F (TACGGRAGGCAGCAG) and 3271-16S-R
(GGACTACCAGGGTATCTAAT). PCR was performed with
two microlitres of sputum DNA mixture in a final volume of 20
microlitres containing 0.35 U High-Fidelity Expand Polymerase
(Roche), the provided Expand buffer, each dNTP at 200 microM,
each primer at 4 microM, and a final MgCl2 concentration of
3 mM. An initial denaturation step of 3 minutes at 94uC was
followed by 40 cycles consisting of 30 seconds at 94uC, 30 seconds
at 50uC, and 30 seconds at 72uC. The reaction was terminated
with 10 minutes of extension at 72uC. All PCRs were prepared
under a laminar flow hood located in a different room from where
the PCRs were analysed. PCRs were carried out using a Techne
TC-312 thermocycler, model FTC3102D. The PCR products
were analysed in a 1% agarose gel containing Ethidium bromide
(0.5 microg/ml).
Pan-fungal PCR Targeting ITS2
The pan-fungal PCR described by Delhaes et al [16] was used.
It amplifies a 340 to 360 bps fragment of the ITS2 region from all
major fungi phyla. The primers were 3271-ITS2F (CARCAAYG-
GATCTCTTGG) and 3271-ITS2R (GATATGCTTAAGTT-
CAGCGGGT). The PCR conditions were exactly the same as
used for the 16S rRNA eubacterial PCR (see above). Pan-fungal
PCR products were only obtained after random amplification of
the sputa DNA mixtures. Random amplification was carried out
using two microlitres of sputum DNA mixture and the Illustra
GenomiPhi V2 DNA Amplification Kit according to the
manufacturer’s instructions (GE Healthcare, Glattbrugg, Switzer-
land). As a control, Saccharomyces cerevisiae genomic DNA was
readily amplified without previous random amplification, suggest-
ing that the ITS2 primers performed properly.
Real-time PCR for A. fumigatus
The real-time PCR specific for A. fumigatus amplified a 85 bps
fragment of the mitochondrial cytochrome B. The pipeting
TECAN EVO 150 robot (8 channels) was used to prepare a
reaction mixture containing master mix ABI Taqman universal
PCR, primer AFF (TTGTATTCTTCATGCCTAACGCA),
primer AFR (CGGAACAATAGCAGGTGGAGTT), and the
probe (FAM-AGGTGATAGTGAAAATTATGTTATGGC-
TAATCCAATGC-BHQ1). Each PCR reaction included 15 ml
of reaction mixture and 5 ml of sputum DNA mixture. Real-time
PCR was performed using Taqman 7900 (Applied Biosystems,
Zug, Switzerland). After 2 minutes at 50uC and 10 minutes at
95uC, 45 cycles of 15 seconds at 95uC and 1 minute at 60uC were
performed. The conversion of Cts in the target concentration was
obtained using a calibration curve obtained by amplifying
successive dilutions of a plasmid containing the A. fumigatus target
sequence. The absence of inhibition was tested by a reaction
containing the tested DNA and 1,000 copies of the plasmid
containing the target. Each sample was analysed in duplicate. The
limit of detection was one to ten copies of the target per reaction.
Cloning, Sequencing and Classification of PCR Sequences
The PCR products were extracted from the gel using a
QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany), and
sub-cloned using a TOPO TA cloning kit and One Shot
DH5alpha-T1 competent cells according to the manufacturer’s
instructions (Invitrogen, Life Technologies, Lucern, Switzerland).
They were sequenced using a reverse M13(-20) primer, Big Dye
Terminator DNA sequencing kit, and an ABI PRISM 3100
automated sequencer (both from Perkin-Elmer Biosystems,
Rotkreuz, Switzerland). Eubacterial 16S rRNA sequences were
identified by comparison using BLAST against two databases of
the National Centre for Biotechnology Information (NCBI, www.
ncbi.nlm.nih.gov): ‘‘reference RNA sequences’’ and ‘‘16S ribo-
somal RNA sequences (bacteria and archea)’’. Both databases
provided identical results at the genus level. For pan-fungal ITS2
sequences, the NCBI ‘‘nucleotide collection’’ database was used.
Sequences were classified to a genus-level using a 95% global
identity threshold. The procedure of PCR followed by sub-cloning
and sequencing was repeated twice. The sequences of PCR clones
were not deposited in a public database because of their limited
quality resulting from single strand sequencing.
Results
Rationale
The Illumina HTS technology was chosen for WGS because (i)
it requires small amounts of DNA, avoiding random DNA
amplification, a technique which may introduce biases in the
proportions of the different microbial species, (ii) it produces large
amounts of reads which ensures analysis of the microbiota despite
the presence of a large proportion of human DNA (about 80%),
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and (iii) it is less expensive than other technologies, allowing
analysis of more samples as required for future studies. We used
several different DNA extraction procedures to decrease possible
bias related to the different cell wall structures, and we pooled the
DNA extracts before direct Illumina HTS and PCRs. This was
meant to ensure the detection of as many different groups of
microorganisms as feasible, and thus improve the enumeration of
microbial diversity. Routine microbiological cultures, as well as
eubacterial and pan-fungal PCRs, followed by sequencing sub-
clones, were applied to the same DNA preparations for
comparison.
Dataset Processing
To reduce the size of the DNA sequence datasets obtained from
the two CF sputa, most human reads were filtered out. The
filtering parameters were designed to ensure that all non-human
reads were kept. The accuracy of the phylogenomic classification
methods increasing with the size of the reads, we attempted to
assemble our filtered reads into contigs. Both tested programs
(Velvet [31] and SPAdes [32]) assembled only ca. 15% of the reads
into small contigs (70% ,1 kb). This poor assembly performance
is clearly linked to the short length of the reads investigated, as well
as to the great mixture of organisms present in our samples (see
below). Considering the minor improvement in sequence length
and added risk of creating chimeric contigs, we decided to perform
all further analyses using the unassembled raw reads.
Phylogenomic Classification
To determine the composition of the microbiota, we used three
different methods of phylogenomic classification. First, ribosomal
DNA sequences were searched using BLAST against the SILVA
rRNA library, and a lowest common-ancestor approach was used
to assign a taxon to each matching read. The two other methods,
MetaPhlan and MetaPhyler, consisted in searching for clade-
specific marker genes. In addition, we tried the composition-based
method TAXY designed to be used with short reads [33], but it
did not produce convincing results. Indeed, different results were
obtained whether it was applied on complete or filtered datasets,
which was not the case with the other three methods.
Populations of the Observed Microbial Genera
The populations of microbial genera found in the two CF sputa
using WGS, cultures, and PCRs are represented in Figure 1. The
short Illumina reads and the sequences from the PCRs allowed for
confident identification only at the genus level. For the two
samples, the three methods of read classifications provided similar
bacterial microbiota compositions.
Bacterial Members of the Microbiota
As far as bacterial members of the microbiota are concerned,
the results of WGS were consistent with those of the cultures and
eubacterial PCR for dominant genera: sputum 1 was enriched in
Haemophilus spp., whereas Staphylococcus spp. and Streptococcus spp.
predominated in sputum 2. The abundant ‘‘Coryneform bacteria’’
observed in the cultures from sputum 2 include the genus Rothia
and thus may correspond to the 0.9 to 4.8% of WGS and PCR
sequences attributed to this genus. However, some genera
evidenced by WGS were not detected by cultures and PCRs, i.e.
Neisseria spp. in sputum 1, and Haemophilus spp. plus Gemella spp. in
sputum 2. In contrast, WGS detected all genera evidenced by
cultures and PCRs, although sometimes in lower proportion (e.g.
Staphylococcus spp. in sputum 1), or in higher proportion
(Haemophilus spp. in sputum 1). WGS also evidenced in both sputa
minorities of anaerobic genera (Veillonella, Prevotella, Fusobacterium),
as well as other genera (Gemella, Moraxella, Granulicatella) which were
not specifically searched by cultures, and which were not detected
by PCR, possibly because we analysed relatively few sub-clones.
One eubacterial PCR sub-clone from sputum 2 corresponded to
an Enterococcus sp., and might not have been differentiated from
Streptococcus spp. by WGS because of the short reads.
Fungal Members of the Microbiota
As far as the fungal members of the microbiota are concerned,
cultures detected yeasts in sputum 1, and C. albicans plus A.
fumigatus (14 colonies) in sputum 2 (Figure 1). Pan-fungal PCRs
detected only Candida in both sputa, suggesting that the yeasts
evidenced in the cultures from sputum 1 belonged to that genus.
Notably, in contrast to the eubacterial PCRs, pan-fungal PCRs
necessitated previous random amplification of sputa DNA to
obtain products, suggesting a low fungal load. Nevertheless, both
sputa were positive using a real-time PCR specific for A. fumigatus
cytochrome B, evidencing approximately 34 and 9,500 cells per ml
of sputum for sputa 1 and 2 respectively (considering ten
mitochondria per haploid cell). On the other hand, WGS did
not permit the detection of any fungi. Because of this apparent
discrepancy, an extensive search for fungal sequences in the non-
filtered Illumina read datasets was performed. First, we searched
for fungal ITSs by BLAST against the relevant databases. Second,
we looked for homology between the reads and all currently
available fungal proteins. The two methods did not provide any
significant clues to the presence of fungal sequences. In a
complementary attempt, the non-filtered datasets were mapped
on different genomes of the genus Candida and on the human
genome. Only 203 and 1,533 reads for sputa 1 and 2 respectively
aligned to a Candida genome but not to that of Homo. The same
analysis using different genomes of the genus Aspergillus respectively
identified only 230 and 195 reads. We concluded that the Candida
or Aspergillus sequences were possibly present but represented only
an extremely low proportion of all reads present in the two
datasets (,0.001%).
Discussion
To determine the composition of microbiota present in CF
lungs using WGS, we used three methods of phylogenomic
classification which gave similar results, biases due to random
DNA amplification were avoided, and several DNA extraction
procedures were used, providing confidence in the microbiota
compositions obtained. As far as bacteria are concerned, our
results suggest that these compositions are much more compre-
hensive than those obtained by routine cultures and eubacterial
PCR. Indeed, several genera which are easy to grow and were
abundant according to WGS were not evidenced by these former
methods. Moreover, several genera detected by WGS, although in
low amounts, would have required specific culture conditions or
deep sequencing of the PCR products to be detected. As far as
fungi are concerned, WGS suggested that they were at extremely
low concentrations in the two microbiota, whereas cultures and
PCRs detected them. This discrepancy is probably not due to the
non-extraction of fungal DNA because positive pan-fungal PCRs
and A. fumigatus qPCR were obtained from the same DNA
preparations. In addition, the beads-beating DNA extraction
procedure used has been specifically developed for fungi and its
efficiency has been observed during the last two years on about
200 samples for diagnosis purpose. On the other hand, culture and
PCR approaches can detect tiny numbers of fungal cells
representing very small proportions of the population because
Whole Genome Sequencing Cystic Fibrosis Microbiota
PLOS ONE | www.plosone.org 4 March 2014 | Volume 9 | Issue 3 | e90934
both are very sensitive as they were developed specifically to detect
fungi, i.e. the culture relies on a selective medium inhibiting
bacterial growth, and the PCR primers were designed to amplify
only fungal sequences. A low fungal load in the two sputa is also
suggested by the fact that DNA had to be randomly amplified to
obtain PCR products with pan-fungal PCR.
The composition of the two cystic fibrosis microbiota obtained
using WGS is consistent with those previously reported in
paediatric CF patients, i.e. with a predominance of H. Influenzae
[10], of Staphylococcus [34], or of Streptococcus [11]. Most bacterial
genera revealed by WGS to be present in low amount in our work
have been previously detected using PCR in CF lungs (Veillonella,
Prevotella, Gemella, Moraxella, Rothia, Fusobacterium) [11,13,14,16].
Previous studies using PCR suggested that Gemella might play a
direct role in and/or be a biomarker for the exacerbation of lung
inflammation in CF patients [13]. The Streptococcus milleri group
spp. have also been reported to be associated with such episodes of
exacerbation [35]. However, these observations remained contro-
versial because the latter association was not confirmed [13], and
another study suggested that the same S. milleri group spp. play an
important role in increasing the biodiversity of CF lung
microbiota, promoting patient stability [14]. A varying abundance
of these bacteria has been suggested to play a role in this
controversy [14]. These conflicting observations further under-
score the crucial need for a robust and holistic method providing a
Figure 1. Populations of microbial genera/species observed in CF sputa using different methods. The percentage of the whole
population is given for each genus/species. WGS: DNA extracted from sputa was sequenced using Illumina high throughput technology and the
reads were attributed to a bacterial taxon using three phylogenomic classification methods. Cultures: routine procedure for culturing respiratory
specimens from CF patients was applied. Low (+) to high (+++) quantity is given in parentheses for each genus/species. Streptococcus spp., Neisseria
spp., Coryneform bacteria, C. albicans, and yeasts were considered as part of the oropharyngeal flora; thus, not all were identified at the species level.
PCRs: PCR products obtained from DNA extracted from sputa were subcloned and sequenced. The number of clones sequenced is given in
parentheses for each genus; it is the total of two separate experiments. (A) Sputum 1. (B) Sputum 2.
doi:10.1371/journal.pone.0090934.g001
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qualitative and quantitative characterisation of microbiota in CF
lungs.
Our study presents several limitations. First, despite using
several DNA extraction methods in parallel to detect as many
microbial groups as possible, we cannot exclude biases in the
proportions of microbiota members due to varying efficiencies of
DNA extraction. This issue will require the analysis of samples
spiked with a precise amount of a given species and/or the analysis
of large numbers of samples known to contain a given amount of
bacteria and fungi, as determined by another reference method,
such as CFU determination. Such experiments will help to assess
extraction efficiency for different microorganisms, and to improve
the procedure. Second, uneven sequencing coverage resulting
from varying GC content may have led to incorrect estimation of
the abundance of some members of the microbiota, although the
Illumina technology has been reported to be one of the less biased
in this respect [36]. Third, the shortness of the reads may have
provoked some imprecise classifications which may explain
differences in the proportions of some genera between the three
methods of classifications, e.g. Neisseria spp. and Haemophilus spp. in
sputa 1 and 2, respectively. Fourth, our WGS procedure also
sequenced DNA from dead cells, which may mask variations in
microbiota composition. This can be avoided by the use of
propidium monoazide (PMA), which only destroys the DNA of
dead cells because this toxic compound is excluded from viable
ones [15]. Comparison with and without PMA treatment might
prove useful in the future to understand CF microbiota evolution.
Another limitation is that we did not look for reads from DNA
viruses. Viruses may play an important role in CF lung disease
[37], and we plan to analyse them in the future. Finally, the use of
spontaneous sputa rather than bronchoalveolar lavage (BAL)
might constitute a limitation because of a possible contamination
of sputa by upper-airway flora. There is an ongoing debate with
conflicting results about the sample to use in order to obtain the
best representation of lung microbiota: spontaneous sputum,
induced sputum, throat swabs, and/or BAL. BAL presents the
major problem in that it generally cannot sample all the different
microbial communities which are compartmentalised within
different areas of CF lungs [38]. Moreover, BAL is invasive and
has a technical requirement, particularly for repeated assessment.
In children there is, in addition, the need for a general anaesthesia.
In the view of the latter issues and to prepare our future studies in
paediatric patients, we chose to exploit sputa. To improve the
quality of sputa, we intend to reduce the oral flora using
mouthwash with sterile saline 0.9% prior to expectoration.
Our results suggest that WGS using direct Illumina HTS
provides, in a single analysis, microbiota compositions which are
more comprehensive and better cover the different taxonomic
diversity than any other approaches. Moreover, the ever-
increasing read lengths should allow identification of these
microbes at the species level in the near future. Importantly, the
approach endows few biases, as well as less risk of contamination
because of fewer manipulations than PCR-based approaches. The
cost is presently high, but it is expected to decrease, and can be
further reduced by the opportunity to multiplex. Thus, together
with an improvement in phylogeny classification pipelines, it
should soon be feasible to analyse many samples quickly and at a
low price. In conclusion, it is likely that WGS using direct HTS
will prove useful for studying the evolution of CF lung microbiota
over time, and this may prove very important to improve care for
CF patients suffering from exacerbations. Moreover, such a direct
WGS approach will also prove useful in studying other microbiota.
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